Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05099003
Title	A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	National Cancer Institute (NCI)
Indications	glioblastoma high grade glioma diffuse midline glioma, H3 K27M-mutant brain stem glioma anaplastic astrocytoma
Therapies	Selinexor
Age Groups:	adult \| child
Covered Countries	USA \| NZL \| CAN \| AUS